{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:59:26Z","timestamp":1775152766392,"version":"3.50.1"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Active anti-HIV therapy can induce hypertriglyceridemia, low high-density lipoprotein (HDL) and insulin resistance, eventually accompanied by clinical lipodystrophy, associated loss of subcutaneous adipose tissue and an increase in abdominal adiposity. The frequency of these metabolic disorders is approximately 50% and host genetic factors might confer particular susceptibility. Variants of apolipoproteins (apo) A5 and C3, interacting with<\/jats:p><jats:p>Clin Chem Lab Med 2007;45:815\u201321.<\/jats:p>","DOI":"10.1515\/cclm.2007.140","type":"journal-article","created":{"date-parts":[[2007,7,8]],"date-time":"2007-07-08T14:26:10Z","timestamp":1183904770000},"source":"Crossref","is-referenced-by-count":14,"title":["Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy"],"prefix":"10.1515","volume":"45","author":[{"given":"Eric","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelise","family":"Genoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josette","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Massip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Perret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref331","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1089\/088922201753341988","article-title":"Synergistic antiadi - pogenic effects of HIV type I protease inhibitors with tumor necrosis factor alpha : suppression of extracellular insulin action mediated by extracellular matrix - degrad - ing proteases","volume":"17","author":"Mondal","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.90.10.4562","article-title":"Bres - low JL An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and untranslated region polymorphisms","volume":"39","author":"Dammerman","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/135965350601100310","article-title":"Nazih - San - derson Association of apolipoproteins and E with metabolic changes in HIV - infected adults treated with protease - inhibitor - containing antiretrovtral therapy","volume":"3","author":"Bard","year":"2006","journal-title":"J Antiviral Ther"},{"key":"ref91","first-page":"276","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissue , due to the accu - mulation of activated sterol regulatory element - binding proteins in the nucleus","volume":"9","author":"Riddle","year":"2001","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleosidic analogue reverse transcrip - tase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/317426","article-title":"Impact of switching from human immunodeficiency virus type protease inhibitors to efavirenz in successfully treated adults with lipodystro - phy","volume":"31","author":"Martinez","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"III metabolic syndrome and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J Lipid Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance , beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s004390050259","article-title":"de Hypertriglyceridemia and the apolipoprotein CIII gene locus : lack of association with the variant insulin response element in Italian school children","volume":"98","author":"Shoulders","year":"1996","journal-title":"Hum Genet"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apo - lipoprotein B from degradation by the proteasome : a potential mechanism for protease inhibitor - induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"ref251","first-page":"3","article-title":"Modeling the influence of APOC APOE and TNF polymorphisms on the risk of antiretroviral therapy - associated lipid disorders","volume":"26","author":"Tarr","year":"2005","journal-title":"J Infect Dis"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.15.7.963","article-title":"Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI CII CIII and E","volume":"15","author":"Clavey","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref71","first-page":"531","article-title":"Lipodystrophies related to antiretroviral treatment of HIV infection","volume":"22","author":"Capeau","year":"2006","journal-title":"Med Sci"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/00002030-200112070-00007","article-title":"Interaction between apo C - III variants and protease inhibitors contributes to high triglycerides \/ low HDL levels in treated HIV - patients","volume":"15","author":"Fauvel","year":"2001","journal-title":"AIDS"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00002030-200210180-00005","article-title":"TNFa - promoter region polymorphisms in HIV - positive patients with lipodystrophy","volume":"16","author":"Maher","year":"2002","journal-title":"AIDS"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0022-2275(20)33507-0","article-title":"de Bruin Association of plasma lipids and apolipoproteins with the insulin response element in the apo - III promoter region in familial combined hyperli - pidemia","volume":"40","author":"Groenendijk","year":"1999","journal-title":"J Lipid Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy , hyper - lipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200309260-00024","article-title":"Lack of correlation between SREBF genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapy","volume":"17","author":"Yang","year":"2003","journal-title":"AIDS"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118324","article-title":"Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyeridemia","volume":"96","author":"Li","year":"1995","journal-title":"J Clin Invest"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200110190-00020","article-title":"A single - nucleotide polymorphism in the sterol - regulatory element - binding protein c gene is predictive of HIV - related hyperlipoproteinemia","volume":"15","author":"Miserez","year":"2001","journal-title":"AIDS"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","article-title":"Mod - ulation of lipoprotein lipase activity by apolipoproteins Effect of apolipoprotein C - III","volume":"75","author":"Wang","year":"1985","journal-title":"J Clin Invest"},{"key":"ref81","first-page":"2625","article-title":"HIV pro - tease inhibitors stimulate hepatic triglyceride synthesis Arterioscl Thromb Vasc","volume":"20","author":"Lenhard","year":"2000","journal-title":"Biol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element - binding protein - intranuclear localization inhibits preadipocyte differentiation , and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"ref271","first-page":"280","article-title":"Pan - nachio Apolipoprotein AV accelerates plasma hydrolysis of triglyceride - rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase","author":"Merkel","year":"2005","journal-title":"J Biol Chem"},{"key":"ref51","first-page":"354","article-title":"Mitochondrial toxicity induced by nucleoside - analogue reverse - transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral - therapy - related lipodys - trophy","volume":"5","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"ref41","first-page":"1043","article-title":"I and apolipopro - tein SAA half - lives during acute inflammation and amy - loidogenesis","author":"Tape","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"ref261","first-page":"1914","article-title":"Protease inhibitor - associated dyslipi - demia in HIV - infected patients is strongly influenced by the APOA C gene variation","volume":"5","author":"Guardiola","year":"1131","journal-title":"Clin Chem"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"Orband - Mil - ler HIV protease inhibitors block adipogenesis and increase lipolysis in vitro","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antiviral Res"}],"container-title":["Clinical Chemical Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2007.140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T05:51:19Z","timestamp":1683957079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2007.140\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":28,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1515\/cclm.2007.140","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}